EDGAR Filing Documents for 0001193125-08-047692

Form 8-K - Current report:

SEC Accession No. 0001193125-08-047692

Filing Date

2008-03-05

Accepted

2008-03-05 14:15:11

Documents

Period of Report

2008-03-03

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	d8k.htm	8-K	30797
2	INDENTURE BETWEEN CELL THERAPEUTICS, INC. AND U.S. BANK NATIONAL ASSOCIATION	dex41.htm	EX-4.1	420971
3	FORM OF WARRANT	dex42.htm	EX-4.2	66060
4	OPINION OF HELLER EHRMAN LLP	dex51.htm	EX-5.1	11274
5	FORM OF PURCHASE AGREEMENT, DATED MARCH 3, 2008	dex101.htm	EX-10.1	120331
6	STATEMENT REGARDING COMPUTATION OF EARNINGS TO FIXED CHARGES	dex121.htm	EX-12.1	22169
7	T-1 STATEMENT OF ELIGIBILITY	dex251.htm	EX-25.1	34671
8	PRESS RELEASE DATED MARCH 4, 2008	dex991.htm	EX-99.1	9265
9	GRAPHIC	g37378ex991.jpg	GRAPHIC	6293
	Complete submission text file	0001193125-08-047692.txt		726091

Mailing Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119

Business Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119 2062707100

CELL THERAPEUTICS INC (Filer) CIK: 0000891293 (see all company filings)